Log In
    ZOMDF
    $0.09
    (1.95%)
    FLWS
    $3.83
    (0.26%)
    ACCO
    $4.13
    (3.25%)
    ARLP
    $25.63
    (3.72%)
    AUIAF
    $0.15
    (3.5%)
    AZZ
    $148.64
    (-0.84%)
    BTBT
    $1.35
    (-1.46%)
    BTM
    $0.49
    (0%)
    CVKD
    $2.06
    (0.98%)
    LCE:CA
    $0.26
    (-1.89%)
    COCP
    $0.92
    (2.07%)
    CDRO
    $9.39
    (1.29%)
    CVGI
    $4.54
    (-1.73%)
    LODE
    $3.11
    (3.67%)
    CMTL
    $1.82
    (5.2%)
    CNDT
    $1.51
    (2.03%)
    CXW
    $31.21
    (-0.45%)
    CMLS
    $0.01
    (0%)
    DRCT
    $2.6
    (1.96%)
    DLHC
    $5.22
    (2.55%)
    SSP
    $2.96
    (-1%)
    ELDN
    $3.57
    (-0.28%)
    EVC
    $11.08
    (3.75%)
    EDRY
    $24.8
    (2.9%)
    ESEA
    $76.11
    (-1.14%)
    FAT
    $0.16
    (0%)
    RAIL
    $8.52
    (1.43%)
    GDEV
    $12
    (-4.76%)
    GOVX
    $0.76
    (3.93%)
    GOCO
    $0.3
    (0%)
    GHM
    $104.3
    (0.36%)
    GLDD
    $17
    (0%)
    GYRE
    $7.58
    (-1.88%)
    HMENF
    $1.83
    (-3.31%)
    III
    $4.01
    (4.02%)
    IPOOF
    $10.53
    (-2.64%)
    KELYA
    $15.72
    (3.69%)
    KTOS
    $49.45
    (4.44%)
    LUCK
    $7.06
    (2.62%)
    MAIA
    $1.28
    (3.23%)
    MGROF
    $0.26
    (-3.72%)
    NTRB
    $2.98
    (0%)
    OCGN
    $1.26
    (4.13%)
    PERF
    $1.93
    (0%)
    QMCI
    $0.15
    (0%)
    RGP
    $3.88
    (2.92%)
    SGA
    $8.53
    (-0.52%)
    SHWZ
    $0
    (0%)
    SHIP
    $16.14
    (-0.25%)
    SLQT
    $0.72
    (12.37%)
    SKYX
    $1.16
    (0.87%)
    SNAL
    $4.95
    (-3.7%)
    GEO
    $30.93
    (0.03%)
    ODP
    $28
    (0%)
    TNXP
    $10.37
    (4.96%)
    TSQ
    $5.93
    (-2.95%)
    TZOO
    $10.21
    (1.85%)
    UNCY
    $5.13
    (-5%)
    VVX
    $87.31
    (4.48%)
    VNCE
    $6.05
    (1.94%)
    XELB
    $1.27
    (3.25%)
    ZOMDF
    $0.09
    (1.95%)
    FLWS
    $3.83
    (0.26%)

    channelchek-in

    ‌
    7/27/2026

    argenx Pays an 86% Premium for Forte Biosciences. What Made a Clinical-Stage Biotech Worth $2.2 Billion

    argenx (Euronext & Nasdaq: ARGX) announced Monday it has entered into a definitive agreement to acquire Forte Biosciences (Nasdaq: FBRX) for $77 per share in cash, a total equity value of approximately $2.2 billion. The price represents an 86% premium to Forte’s volume-weighted average trading price since July 9, when the company reported positive Phase 1b data in vitiligo. That is an unusually large premium even by the standards of this year’s active biotech M&A market, and it reflects just how quickly clinical data can transform a small cap company’s valuation.

    0
    3 min read
    • ‌
      Apple Passed Nvidia as the World’s Most Valuable Company. Spending Less on AI Just Became a Winning Strategy

      Apple Passed Nvidia as the World’s Most Valuable Company. Spending Less on AI Just Became a Winning Strategy

      Apple reclaimed the title of the world’s most valuable public company Mond...

      3 min read

    • BlackRock Is Selling $12.3 Billion in Bonds to Fund a Meta Data Center. Wall Street Is Watching to See Who Buys

      3 min read

    • Receive FREE Research, News, Video, and Event Updates in Your Inbox!

    • Michael Burry Says This Market Feels Like 1999. Here Is What That Warning Means for Small Caps

      4 min read
    View all

    News

    7/27/2026

    Release – Alliance Resource Partners, L.P. Reports Second Quarter Financial and Operating Results; Declares Quarterly Cash Distribution of $0.60 Per Unit; and Updates 2026 Guidance

    17 min read
    ‌
    Release – Alliance Resource Partners, L.P. Reports Second Quarter Financial and Operating Results; Declares Quarterly Cash Distribution of $0.60 Per Unit; and Updates 2026 Guidance
    7/27/2026

    Release – V2X Joins S&P SmallCap 600 Index

    2 min read
    ‌
    Release – V2X Joins S&P SmallCap 600 Index
    7/27/2026

    Release – Kratos Delivers Critical Component for Lockheed Martin’s High-Performance Propulsion Initiative

    5 min read
    ‌
    Release – Kratos Delivers Critical Component for Lockheed Martin’s High-Performance Propulsion Initiative
    7/27/2026

    Release – First Phosphate Selected for “Filon” Fastrack Status with the Québec Ministry of Natural Resources and Forests

    5 min read
    ‌
    Release – First Phosphate Selected for “Filon” Fastrack Status with the Québec Ministry of Natural Resources and Forests
    View all

    Research Reports

    SelectQuote (SLQT) – Q4 Preview—Building Toward a Cash Flow InflectionS(Resources Connection (RGP) – Reports 4Q26 Results In-line with ExpectationsRC(Aurania Resources (AUIAF) – Board Member Assumes Expanded RoleAR(Cadrenal Therapeutics (CVKD) – Strategic Changes Create A New Cardiac Acute Critical Care FranchiseCT(
    View all

    Video Content

  • ‌
    Kuya Silver

    Kuya Silver

    C-Suite Interview
    7/20/2026
  • ‌
    First Phosphate Corp.

    First Phosphate Corp.

    C-Suite Interview
    6/22/2026
  • ‌
    DHI Group Inc.

    DHI Group Inc.

    Conference Presentation
    6/4/2026
  • ‌
    Ocugen

    Ocugen

    Conference Presentation
    6/4/2026
    • View all

    Movers

    Symbol
    Change
    DFNS
    201.15%
    ENTX
    91.22%
    LVWR
    66.44%
    NCTY
    41.43%
    FBRX
    39.65%
    View all
    Log In